Market News AIOpen the app

EVMN stock news · Evommune, Inc.

Stories about Evommune, Inc. (EVMN) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for EVMN

Follow Evommune, Inc. (EVMN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for EVMN
Free on the App Store and Google Play, or on the web.
  1. Nov 14, 2026, 9:07 PM ET · Opinion

    Needham keeps a 'Buy' rating for Evommune but lowers its price target from $28 to $25.

    Neutral

    Needham cut its target for Evommune from $28 to $25 but kept its Buy rating. These mixed views do not report a change in the company's business outlook.